Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 97 of 110 Updated Nov 17, 2026

Chonluten

Khavinson lung bioregulator

RUSSIAN RESEARCH · KHAVINSON SHORT PEPTIDE BIOREGULATOR

▓ 3 indexed citations across PubMed (1), EuropePMC (2).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

3 citations across 1 tier

Tap any tier to jump to that section of the bibliography.

Mechanism of action

Tissue-specific gene expression modulation in respiratory epithelium

Researched effects

Lung/bronchial epithelial support; mucosal function

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

Oral capsule 1-2x daily

Known concerns

Limited Western evidence

Top-ranked picks

3 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.

    International journal of molecular sciences · 2022 — RESEARCH ARTICLES · AUTHORITY 34.2

  2. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers.

    2022 — RESEARCH ARTICLES · AUTHORITY 34.2

  3. Peptides: Prospects for Use in the Treatment of COVID-19.

    2020 — RESEARCH ARTICLES · AUTHORITY 34.0

Full citation library

Year distribution

Research Articles

3
  1. 1.

    Avolio F, Martinotti S, Khavinson VK, Esposito JE, et al. · International journal of molecular sciences · 2022 · PMID 35408963

    This study evaluates the effects of five different peptides, the Epitalon

  2. 2.

    Khavinson V, Linkova N, Dyatlova A, Kuznik B, Umnov R. · 2020 · PMID 32987757

    There is a vast practice of using antimalarial drugs, RAS inhibitors, serine protease inhibitors, inhibitors of the RNA-dependent RNA polymerase of the virus and immunosuppressants for the treatment of the severe form of COVID-19, which often occurs in patients with chronic diseases and older persons. Currently, the clinical efficacy of these drugs for COVID-19 has not been proven yet. Side effects of antimalarial drugs can worsen the condition of patients and increase the likelihood of death. P…

  3. 3.

    Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. · 2022 · PMID 35887081

    Ultrashort peptides (USPs), consisting of 2-7 amino-acid residues, are a group of signaling molecules that regulate gene expression and protein synthesis under normal conditions in various diseases and ageing. USPs serve as a basis for the development of drugs with a targeted mechanism of action. The purpose of this review is to systematize the available data on USP transport involving POT and LAT transporters in various organs and tissues under normal, pathological and ageing conditions. The ca…

Curated sources on file

3
  1. 1.
  2. 2.
  3. 3.
    Note: Primary literature on this peptide is published largely in Russian gerontology journals (Adv Gerontol, Bull Eksp Biol Med). English-indexed sources are limited to comprehensive Khavinson-laboratory reviews; entry confidence is correspondingly lower.

Continue reading